Oral phenytoin pharmacokinetics during omeprazole therapy.

89Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

1. In a double‐blind crossover study 10 healthy males received either placebo or omeprazole (40 mg day‐1) for 9 days, a single dose of phenytoin (300 mg) being taken on the seventh day. 2. Omeprazole significantly increased the area under the curve (0 to 72 h) of phenytoin (mean +/‐ s.e. mean) from 121.6 +/‐ 14.0 to 151.4 +/‐ 13.6 micrograms ml‐1 h) (P less than 0.01). 3. The peak concentration, and apparent elimination half‐life of phenytoin also tended to be increased though not significantly. 4. The omeprazole‐phenytoin interaction observed may be clinically important because of the low therapeutic index associated with phenytoin. 1987 The British Pharmacological Society

Cite

CITATION STYLE

APA

Prichard, P., Walt, R., Kitchingman, G., Somerville, K., Langman, M., Williams, J., & Richens, A. (1987). Oral phenytoin pharmacokinetics during omeprazole therapy. British Journal of Clinical Pharmacology, 24(4), 543–545. https://doi.org/10.1111/j.1365-2125.1987.tb03209.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free